Mauna Kea Technologies - Confocal Endomicroscopy

Cellvizio Live Show at IMAGE, Humanitas Hospital, Milan, Italy

Fri, 09 Mar 2012 10:35:42 +0100

Cellvizio will be showcased at IMAGE: The 2nd International Live Endoscopy Course, June 14 - 16 at Humanitas Hospital, Milan, Italy.

International Digestive Disease (IDD) Forum, Hong Kong

Wed, 02 May 2012 15:55:52 +0100

This forum, organized by the Institute of Digestive Disease and the Chinese University of Hong-Kong offers cutting-edge advancements in the diagnosis and management of liver and gastrointestinal diseases, including but not limited to state-of-the-art lectures, clinical updates, live endoscopy demonstration, and challenging clinical cases.

Digestive Disease Week - DDW

Tue, 28 Feb 2012 15:00:41 +0100

Digestive Disease Week® (DDW) is the world's leading educational forum for academicians, clinicians, researchers, students and trainees working in gastroenterology, hepatology, GI endoscopy, gastrointestinal surgery and related fields.

MAUNA KEA TECHNOLOGIES RECEIVES 510(k) CLEARANCE FOR PORTFOLIO OF SMALLER DIAMETER CELLVIZIOÂ® MINIPROBES

Wed, 16 May 2012 17:07:12 +0100

Mauna Kea Technologies, leader in the endomicroscopy market and developer of Cellvizio®, the world’s smallest microscope, announced today that the U.S. Food and Drug Administration (FDA) has cleared a portfolio of smaller Cellvizio Miniprobes.

30 Cellvizio abstracts accepted at DDW 2012

Mon, 14 May 2012 14:47:18 +0100

30 Cellvizio abstracts have been accepted at this year's Digestive Disease Week in San Diego, CA , May 19-22, 2012.

MAUNA KEA TECHNOLOGIES ANNOUNCES HIGHLIGHTS OF 4TH ANNUAL INTERNATIONAL CONFERENCE OF CELLVIZIOÂ® USERS (ICCU)

Mon, 14 May 2012 16:23:07 +0100

Over 120 international experts in endoscopy gathered in Rome to discuss use of Cellvizio to improve patient outcomes in digestive, respiratory disease and new indications.

Mauna Kea Donates $100,000 to ASGE's Training Center

Thu, 10 May 2012 17:55:47 +0100

The American Society for Gastrointestinal Endoscopy (ASGE) Foundation has received a donation of $100,000 from Mauna Kea Technologies to ASGE’s IT&T Capital Campaign, a fundraising project to construct a new facility that will provide cutting-edge technology and training to gastroenterology professionals. The donation will be made over five years.

Cellvizio GI Workshop in Irvine, CA, USA

Tue, 13 Mar 2012 11:06:14 +0100

Acquire a basic understanding of how the Cellvizio system works, and learn how to interpret Cellvizio images of the esophagus, bile duct and colon. Live cases will be observed and the latest clinical data and case studies will be analyzed.

Cellvizio featured at Endocon 2012

Fri, 04 May 2012 09:43:53 +0100

Cellvizio was featured in 5 live cases at Endocon 2012, the largest GI event in India. The ERCP case performed by A. Meining and J.H. Moon demonstrated the value of pCLE in characterizing a malignant stricture in real-time.

Interventional Innovations in Digestive Care, New York, USA

Wed, 04 Apr 2012 17:34:32 +0100

This two day course will inform participants of the latest innovations for the management of gastrointestinal diseases and disorders, and will offer a unique opportunity to learn more about the current trends in interventional endoscopic and surgical procedures.

Mauna Kea Technologies Reports 155% First Quarter Sales Growth

Wed, 18 Apr 2012 15:29:25 +0100

Mauna Kea Technologies reported a 155% growth in sales for the first fiscal quarter, ended March 31, 2012 which drove the company’s overall sales for the period to €1.61 million, from €631,000 in the same period last year.

Confocal Endomicroscopy Applications in Interventional Pulmonology

Tue, 28 Feb 2012 12:27:49 +0100

An international meeting and workshop on confocal laser endomicroscopy applications in interventional pulmonology. The faculty consists of distinguished specialists in interventional pulmonology from France, USA and Israel.

The 4th International Conference of Cellvizio Users (ICCU)

Wed, 07 Dec 2011 14:59:13 +0100

Under the chairmanship of Pr. Kenneth Chang (University of California, Irvine, United States) and Dr. Bertrand NapolÃ©on (Hopital privÃ© Jean Mermoz, Lyon, France), a new format with a scientific program will be presented to the expanding Cellvizio users community which includes GI endoscopists, pulmonologists, urologists and surgeons.

Cellvizio News, April 2012

Wed, 02 May 2012 09:48:05 +0100

We are gearing up for the 4th Annual International Conference of Cellvizio Users (ICCU) being held on April 13th-15th in Rome, Italy.

Mauna Kea Technologies Appoints Gilles Brisson Chairman of the Board

Tue, 10 Apr 2012 09:14:53 +0100

Mauna Kea Technologies today announced that the company's Board of Directors appointed new board member Gilles Brisson to the role of Chairman of the Board.

Mauna Kea Technologies Announces Full Year 2011 Financial Results

Wed, 04 Apr 2012 17:34:50 +0100

Sales of Cellvizio® systems and probes to hospitals grew +71%; gross margin reaches record high 68% of sales; cash and cash equivalents of €51 million at Dec. 31, 2011.

SCOPING OUT COLON CANCER

Thu, 29 Mar 2012 10:54:19 +0100

Live webcast on the benefits of using Cellvizio for smarter colonoscopies with Stanley B. Benjamin, MD, chief, and Firas H. Al-Kawas, MD, Division of Gastroenterology, and a testimonial from a patient whose life was saved after a colonoscopy.

The annual Congress of the Federation of the Italian Societies of Digestive Diseases

Tue, 28 Feb 2012 12:01:05 +0100

The annual Congress of the Federation of the Italian Societies of Digestive Diseases, taking place in Naples on March 28-31, will focus on the latest news in national and international research in digestive diseases.

MAUNA KEA TECHNOLOGIES APPOINTS MEDTECH EXPERT TO TOP SALES POSITION IN EMEA REGION

Tue, 27 Mar 2012 17:35:36 +0100

Mauna Kea Technologies announced today the appointment of industry veteran Georges Tabary as Vice President of Sales for the Europe, Middle East, and Africa (EMEA) region. Tabary will focus on structuring an elite sales force and implementing the company's sales strategy for its flagship Cellvizio® products in the EMEA region.

Fostering Innovation and Technology in Digestive and Metabolic Diseases, Palo Alto, CA, USA

Thu, 22 Mar 2012 14:53:02 +0100

Mauna Kea Technologies is pleased to sponsor Fostering Innovation in Digestive and Metabolic Diseases, a conference on GI innovation and technology that brings together medical device companies, reimbursement experts/consultants, policymakers, investors, inventors, physician innovators and key opinion leaders to examine the issues surrounding the development and delivery of new technologies to the GI market.

DGE-BV Westin Grand Hotel Munich, Germany

Tue, 28 Feb 2012 10:58:10 +0100

The 42nd Congress of the German Society for Endoscopy and Imaging Association in Munich.

Scoping Out Colon Cancer: A Free Live Webcast

Tue, 20 Mar 2012 09:48:33 +0100

Cellvizio will be featured in a live webcast on colon cancer prevention hosted by MedStar Georgetown University Hospital.

Advances in Interventional Endoscopy and Laparoscopy - Paying the way to NOTES

Tue, 28 Feb 2012 11:38:16 +0100

Romanian/ English workshop with advances in endoscopy and laparoscopy. State-of-the-art and latest progress on NOTES surgery. Registered attendees will participate in hands-on workshops offering demonstrations and information on the latest endoscopic procedures and devices.

JFHOD 2012: French-speaking days of Digestive Hepato-gastroenterology and Oncology

Wed, 07 Dec 2011 14:26:06 +0100

A French-speaking congress of reference in terms of digestive cancers and diseases gathering 4000 participants each year.

EndoNurse: New AMA Codes May Increase Access to Endoscopic Microscope

Fri, 16 Mar 2012 10:58:45 +0100

Mauna Kea Technologies announced that the American Medical Association's CPT (current procedural terminology) editorial panel has approved three Category I codes to cover use of Cellvizio in the gastrointestinal tract. Th

MAUNA KEA TECHNOLOGIESâ™ CELLVIZIOÂ® IS APPROVED FOR CATEGORY I CPTÂ®Â CODES

Tue, 13 Mar 2012 15:57:20 +0100

Cellvizio® approved for Category I CPT Codes, facilitating reimbursement process in the United States.

MAUNA KEA TECHNOLOGIESâ™ CELLVIZIOÂ® IS APPROVED FOR CATEGORY I CPTÂ® CODES

Fri, 16 Mar 2012 09:33:12 +0100

CellvizioÂ® approved for Category I CPT Codes, facilitating reimbursement process in the United States.

Cellvizio GI Workshop: Cochin Hospital, Paris, France

Wed, 11 Jan 2012 14:25:26 +0100

Cellvizio Live procedures and pCLE image interpretation training. Trainers: Prof. F. Prat and Dr. S. Leblanc. Register now: http://www.cellvizio.net/contact-us

PERSEE PROJECT SUCCESSFULLY MEETS KEY MILESTONE, MAUNA KEA TECHNOLOGIES OBTAINS â¬1.7 MILLION IN FUNDING FROM OSEO

Wed, 08 Feb 2012 14:30:17 +0100

Mauna Kea Technologies (NYSE Euronext: MKEA, FR0010609263), leader in the endomicroscopy market, announced today that PERSEE, the consortium headed by Mauna Kea Technologies, has met a major milestone in its development and has obtained the second installment in funding from OSEO, a public sector institution dedicated to economic development in France.

ADMISSION OF THE MAUNA KEA TECHNOLOGIES SHARE TO THE SRD âoeLONGâ

Mon, 06 Feb 2012 18:00:25 +0100

Mauna Kea Technologies (NYSE Euronext: MKEA, FR0010609263), leader in the endomicroscopy market, today announces the upcoming admission of its share to the “SRD Long-Only” of the Deferred Settlement Service.